SCHEMBL8305964

SCHEMBL8305964

C/C(=N/OCCO)c1ccc(N(C)S(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.49
NR1I2 O75469 1/20 0.47
NR1H3 Q13133 3/20 0.46
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
LIMK2 P53671 1/20 0.44
GAA P10253 2/20 0.44
KDM4E B2RXH2 2/20 0.44
MAPK1 P28482 1/20 0.44
NR1H2 P55055 3/20 0.44
LMNA P02545 2/20 0.44
PKM P14618 1/20 0.44
GBA1 P04062 1/20 0.44
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
NPC1 O15118 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8305966 1.00 L3MBTL1 (0.49) L3MBTL1NR1I2NR1H3MEN1KMT2A
SCHEMBL8305035 0.82 PPARA (0.51) L3MBTL1MEN1KMT2AGAAKDM4E
SCHEMBL8305033 0.82 PPARA (0.51) L3MBTL1MEN1KMT2AGAAKDM4E
SCHEMBL8390039 0.79 NR1I2 (0.48) L3MBTL1NR1I2NR1H3MEN1KMT2A
SCHEMBL8310032 0.79 NR1I2 (0.56) NR1I2NR1H3MEN1KMT2ALIMK2
SCHEMBL4476867 0.77 LMNA (0.69) L3MBTL1MEN1KMT2AMAPK1LMNA
SCHEMBL4476864 0.77 LMNA (0.69) L3MBTL1MEN1KMT2AMAPK1LMNA
SCHEMBL5610797 0.74 LMNA (0.56) L3MBTL1MAPK1LMNAMAPTNPC1
SCHEMBL5610798 0.74 LMNA (0.56) L3MBTL1MAPK1LMNAMAPTNPC1
SCHEMBL12673467 0.74 SIRT2 (0.61) NR1I2NR1H3MEN1KMT2ALIMK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed